Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,850 | 7 | 57.4% |
| Food and Beverage | $26,378 | 1,594 | 38.0% |
| Honoraria | $2,250 | 1 | 3.2% |
| Travel and Lodging | $850.45 | 2 | 1.2% |
| Education | $153.14 | 3 | 0.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Rheumatology | $40,479 | 8 | $0 (2021) |
| ABBVIE INC. | $3,395 | 144 | $0 (2024) |
| Horizon Therapeutics plc | $3,247 | 52 | $0 (2023) |
| Janssen Biotech, Inc. | $3,135 | 139 | $0 (2024) |
| Amgen Inc. | $2,984 | 136 | $0 (2024) |
| UCB, Inc. | $2,333 | 174 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,989 | 171 | $0 (2024) |
| PFIZER INC. | $1,612 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,414 | 121 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,165 | 97 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,413 | 271 | Amgen Inc. ($858.47) |
| 2023 | $4,624 | 226 | Janssen Biotech, Inc. ($993.48) |
| 2022 | $3,804 | 217 | ABBVIE INC. ($538.28) |
| 2021 | $5,520 | 114 | United Rheumatology ($3,750) |
| 2020 | $18,299 | 46 | United Rheumatology ($17,500) |
| 2019 | $13,660 | 288 | United Rheumatology ($7,500) |
| 2018 | $11,025 | 251 | United Rheumatology ($7,500) |
| 2017 | $7,136 | 195 | United Rheumatology ($4,229) |
All Payment Transactions
1,608 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 12/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 12/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $34.54 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $1.23 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 3,840 | 219,394 | $4.8M | $2.5M |
| 2022 | 42 | 3,981 | 192,890 | $4.3M | $2.2M |
| 2021 | 40 | 3,663 | 168,408 | $3.9M | $2.2M |
| 2020 | 39 | 2,997 | 107,040 | $2.9M | $1.7M |
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 497 | 39,362 | $1.1M | $718,888 | 65.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 33 | 10,800 | $669,600 | $363,774 | 54.3% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 68 | 42,848 | $556,920 | $340,337 | 61.1% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 22 | 61,162 | $581,020 | $286,248 | 49.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 24 | 41,400 | $558,900 | $161,870 | 29.0% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 11 | 1,750 | $192,500 | $111,207 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 458 | 1,048 | $162,410 | $102,105 | 62.9% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 17 | 8,650 | $302,750 | $92,013 | 30.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 578 | 1,077 | $102,315 | $63,527 | 62.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 2,150 | $122,550 | $56,802 | 46.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 94 | 403 | $80,600 | $42,774 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 288 | 431 | $47,410 | $29,654 | 62.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 155 | 551 | $60,059 | $24,453 | 40.7% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 24 | 4,200 | $84,000 | $22,562 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 173 | 173 | $36,330 | $21,688 | 59.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 68 | $15,300 | $9,365 | 61.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $13,617 | $8,247 | 60.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 113 | 212 | $17,808 | $7,395 | 41.5% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 95 | 201 | $16,683 | $5,885 | 35.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 260 | 985 | $9,636 | $5,764 | 59.8% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 68 | 109 | $11,445 | $4,016 | 35.1% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | Office | 2023 | 25 | 29 | $7,105 | $3,743 | 52.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 65 | 120 | $8,040 | $3,144 | 39.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 31 | 58 | $5,510 | $2,695 | 48.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 21 | 100 | $8,500 | $2,297 | 27.0% |
About Dr. Amiel Tokayer, M.D
Dr. Amiel Tokayer, M.D is a Rheumatology healthcare provider based in Boynton Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346240694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amiel Tokayer, M.D has received a total of $69,482 in payments from pharmaceutical and medical device companies, with $5,413 received in 2024. These payments were reported across 1,608 transactions from 50 companies. The most common payment nature is "Consulting Fee" ($39,850).
As a Medicare-enrolled provider, Tokayer has provided services to 14,481 Medicare beneficiaries, totaling 687,732 services with total Medicare billing of $8.5M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Boynton Beach, FL
- Active Since 07/28/2005
- Last Updated 01/31/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1346240694
Products in Payments
- KRYSTEXXA (Biological) $3,365
- Cimzia (Drug) $2,092
- RINVOQ (Biological) $1,762
- SIMPONI ARIA (Biological) $1,621
- TREMFYA (Drug) $1,460
- BENLYSTA (Biological) $1,414
- COSENTYX (Biological) $1,365
- XELJANZ (Drug) $1,243
- ORENCIA (Biological) $1,165
- Enbrel (Biological) $1,090
- EVENITY (Biological) $950.95
- Humira (Biological) $831.48
- TALTZ (Drug) $723.05
- PURIFIED CORTROPHIN GEL (Drug) $708.92
- Rituxan (Biological) $689.15
- Tymlos (Biological) $638.50
- COSENTYX (Drug) $623.39
- SAPHNELO (Biological) $598.69
- Otezla (Drug) $468.72
- Tymlos (Drug) $465.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Boynton Beach
Dr. Jonathan Greer, M.d, M.D
Rheumatology — Payments: $963,549
Dr. Kenneth Bresky, D.o, D.O
Rheumatology — Payments: $38,173
Dr. Catherine Garcia, M.d, M.D
Rheumatology — Payments: $28,404
Dr. Maricarmen Quintero, M.d, M.D
Rheumatology — Payments: $14,524
Maria Aldahan
Rheumatology — Payments: $1,004
Dr. Michael Ross, M.d, M.D
Rheumatology — Payments: $391.89